These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 38272206

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impaired Wound Healing, Fibrosis, and Cancer: The Paradigm of Recessive Dystrophic Epidermolysis Bullosa.
    Tartaglia G, Cao Q, Padron ZM, South AP.
    Int J Mol Sci; 2021 May 12; 22(10):. PubMed ID: 34065916
    [Abstract] [Full Text] [Related]

  • 6. TGFβ-signaling in squamous cell carcinoma occurring in recessive dystrophic epidermolysis bullosa.
    Knaup J, Gruber C, Krammer B, Ziegler V, Bauer J, Verwanger T.
    Anal Cell Pathol (Amst); 2011 May 12; 34(6):339-53. PubMed ID: 22002724
    [Abstract] [Full Text] [Related]

  • 7. A novel homozygous splice site mutation in COL7A1 in a Chinese patient with severe recessive dystrophic epidermolysis bullosa and squamous cell carcinoma.
    Huang L, Wong YP, Burd A.
    Int J Dermatol; 2011 Jan 12; 50(1):52-6. PubMed ID: 21182502
    [Abstract] [Full Text] [Related]

  • 8. Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
    Ng YZ, Pourreyron C, Salas-Alanis JC, Dayal JH, Cepeda-Valdes R, Yan W, Wright S, Chen M, Fine JD, Hogg FJ, McGrath JA, Murrell DF, Leigh IM, Lane EB, South AP.
    Cancer Res; 2012 Jul 15; 72(14):3522-34. PubMed ID: 22564523
    [Abstract] [Full Text] [Related]

  • 9. Stromal microenvironment in type VII collagen-deficient skin: The ground for squamous cell carcinoma development.
    Guerra L, Odorisio T, Zambruno G, Castiglia D.
    Matrix Biol; 2017 Nov 15; 63():1-10. PubMed ID: 28126522
    [Abstract] [Full Text] [Related]

  • 10. Reprogramming and Differentiation of Cutaneous Squamous Cell Carcinoma Cells in Recessive Dystrophic Epidermolysis Bullosa.
    Rami A, Łaczmański Ł, Jacków-Nowicka J, Jacków J.
    Int J Mol Sci; 2020 Dec 29; 22(1):. PubMed ID: 33383666
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-145-5p regulates fibrotic features of recessive dystrophic epidermolysis bullosa skin fibroblasts.
    Condorelli AG, Logli E, Cianfarani F, Teson M, Diociaiuti A, El Hachem M, Zambruno G, Castiglia D, Odorisio T.
    Br J Dermatol; 2019 Nov 29; 181(5):1017-1027. PubMed ID: 30816994
    [Abstract] [Full Text] [Related]

  • 12. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma.
    South AP, O'Toole EA.
    Dermatol Clin; 2010 Jan 29; 28(1):171-8. PubMed ID: 19945632
    [Abstract] [Full Text] [Related]

  • 13. Recessive dystrophic epidermolysis bullosa-associated squamous-cell carcinoma: an enigmatic entity with complex pathogenesis.
    Rodeck U, Uitto J.
    J Invest Dermatol; 2007 Oct 29; 127(10):2295-6. PubMed ID: 17853916
    [Abstract] [Full Text] [Related]

  • 14. Functional genotype-phenotype associations in recessive dystrophic epidermolysis bullosa.
    So JY, Nazaroff J, Yenamandra VK, Gorell ES, Harris N, Fulchand S, Eid E, Dolorito JA, Marinkovich MP, Tang JY.
    J Am Acad Dermatol; 2024 Sep 29; 91(3):448-456. PubMed ID: 38735484
    [Abstract] [Full Text] [Related]

  • 15. Significance of sentinel node biopsy in the management of squamous cell carcinoma arising from recessive dystrophic epidermolysis bullosa.
    Rokunohe A, Nakano H, Aizu T, Kaneko T, Nakajima K, Ikenaga S, Matsuzaki Y, Murai T, Tamai K, Sawamura D.
    J Dermatol; 2008 Jun 29; 35(6):336-40. PubMed ID: 18578710
    [Abstract] [Full Text] [Related]

  • 16. APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
    Cho RJ, Alexandrov LB, den Breems NY, Atanasova VS, Farshchian M, Purdom E, Nguyen TN, Coarfa C, Rajapakshe K, Prisco M, Sahu J, Tassone P, Greenawalt EJ, Collisson EA, Wu W, Yao H, Su X, Guttmann-Gruber C, Hofbauer JP, Hashmi R, Fuentes I, Benz SC, Golovato J, Ehli EA, Davis CM, Davies GE, Covington KR, Murrell DF, Salas-Alanis JC, Palisson F, Bruckner AL, Robinson W, Has C, Bruckner-Tuderman L, Titeux M, Jonkman MF, Rashidghamat E, Lwin SM, Mellerio JE, McGrath JA, Bauer JW, Hovnanian A, Tsai KY, South AP.
    Sci Transl Med; 2018 Aug 22; 10(455):. PubMed ID: 30135250
    [Abstract] [Full Text] [Related]

  • 17. Revertant mosaic fibroblasts in recessive dystrophic epidermolysis bullosa.
    Twaroski K, Eide C, Riddle MJ, Xia L, Lees CJ, Chen W, Mathews W, Keene DR, McGrath JA, Tolar J.
    Br J Dermatol; 2019 Dec 22; 181(6):1247-1253. PubMed ID: 30924923
    [Abstract] [Full Text] [Related]

  • 18. Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases.
    Hwang A, Kwon A, Miller CH, Reimer-Taschenbrecker A, Paller AS.
    Orphanet J Rare Dis; 2024 May 21; 19(1):206. PubMed ID: 38769503
    [Abstract] [Full Text] [Related]

  • 19. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression.
    Pourreyron C, Cox G, Mao X, Volz A, Baksh N, Wong T, Fassihi H, Arita K, O'Toole EA, Ocampo-Candiani J, Chen M, Hart IR, Bruckner-Tuderman L, Salas-Alanis JC, McGrath JA, Leigh IM, South AP.
    J Invest Dermatol; 2007 Oct 21; 127(10):2438-44. PubMed ID: 17495952
    [Abstract] [Full Text] [Related]

  • 20. Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa.
    So JY, Nazaroff J, Iwummadu CV, Harris N, Gorell ES, Fulchand S, Bailey I, McCarthy D, Siprashvili Z, Marinkovich MP, Tang JY, Chiou AS.
    Orphanet J Rare Dis; 2022 Oct 17; 17(1):377. PubMed ID: 36253825
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.